Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001209801 | SCV001381251 | uncertain significance | Neurofibromatosis, type 1 | 2019-05-14 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in an individual with clinical features of neurofibromatosis type I (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with lysine at codon 964 of the NF1 protein (p.Thr964Lys). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and lysine. |